Covid-19 Impact on Artificial Vital Organs Market, Global Research Reports 2020-2021
Artificial organ is man-made machine or device that is used to replace the functions of missing or faulty organ and restores the functions of original organ.
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
This report provides a complete quantitative data and qualitative analysis on the global market for Artificial Vital Organs. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Artificial Vital Organs was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Artificial Vital Organs is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Artificial Vital Organs, including the following market information:
Global Artificial Vital Organs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Vital Organs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Vital Organs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Vital Organs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Edwards Lifesciences Corporation, Abbott Diabetes Care, Baxter International, Ekso Bionics, Asahi Kasei Medical, Jarvik Heart, Ottobock Healthcare, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Based on the Application:
Hospitals
Clinics
Research Centers
Others
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
This report provides a complete quantitative data and qualitative analysis on the global market for Artificial Vital Organs. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Artificial Vital Organs was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Artificial Vital Organs is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Artificial Vital Organs, including the following market information:
Global Artificial Vital Organs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Vital Organs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Vital Organs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Artificial Vital Organs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Edwards Lifesciences Corporation, Abbott Diabetes Care, Baxter International, Ekso Bionics, Asahi Kasei Medical, Jarvik Heart, Ottobock Healthcare, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Based on the Application:
Hospitals
Clinics
Research Centers
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
